Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
  • Subscribe
Submit An Article

pain relief

  • Home
  •  
  • pain relief



  • Most Read
  • Latest Comments
  • Wellfully set to jump into $9 billion market with FDA registration for their knee pain patch
    • News

    Pandemic poses opportunity to online learning platform OpenLearning
    Public
  • Wellfully set to jump into $9 billion market with FDA registration for their knee pain patch
    • News

    Novatti partners with Ripple for global blockchain payments network
    Public
  • Wellfully set to jump into $9 billion market with FDA registration for their knee pain patch
    • Opinion

    Is ASX: OOO the riskiest or smartest oil investment?
    Public
  • Wellfully set to jump into $9 billion market with FDA registration for their knee pain patch
    • Market Update

    Markets stage a recovery, but is the selling over?
    Public
  • Wellfully set to jump into $9 billion market with FDA registration for their knee pain patch
    Crowd Media adds voice cloning for immersive celebrity experiences in AI deal
    • Review
    • January 27, 2021
  • Research Note - Rise of the Cashless Economy
    • Review
    • June 3, 2020
  • Novatti to drive Malaysia into the digital payments era with ATX acquisition
    • Review
    • October 20, 2021
  • Retired NFL players endorse Zilosul, Paradigm’s osteoarthritis drug trials
    • Review
    • March 24, 2020
  • Apiam expands equine vet footprint in Queensland in time for breeding season
    • Review
    • June 30, 2021

Latest Articles

  • Wellfully set to jump into $9 billion market with FDA registration for their knee pain patch
    Wellfully set to jump into $9 billion market with FDA registration for their knee pain patch
    • News

  • This $22 million company is changing the future of surgery
    This $22 million company is changing the future of surgery
    • News

  • International expansion as more hospitals register for Pharmaxis’ cancer treatment trials
    International expansion as more hospitals register for Pharmaxis’ cancer treatment trials
    • News

  • Spray On Skin available to over 200,000 more US healthcare providers following purchasing agreement
    Spray On Skin available to over 200,000 more US healthcare providers following purchasing agreement
    • News

  • Pharmaxis reports progress in clinical trials despite COVID affecting industry
    Pharmaxis reports progress in clinical trials despite COVID affecting industry
    • News

  • Wellfully set to jump into $9 billion market with FDA registration for their knee pain patch
    • News

    Wellfully set to jump into $9 billion market with FDA registration for their knee pain patch

    “How much does it hurt, on a scale of 1-10?” Easily the most frustratingly vague of medical questions due to the huge difference in pain thresholds and perceptions. I don’t know about you, but I’m saving my 10 for childbirth.  Nonetheless, when the answer falls beneath an epidural-requiring 10, many of us reach for simple

    Read More
    Public
  • Aussie opioid manufacturer cashed up following $33m sale of facility
    • News

    Aussie opioid manufacturer cashed up following $33m sale of facility

    While prescription opioids have been getting a pretty bad rap over the past few years amid revelations in the US about a certain Sackler family, they still have a vital role to play in healthcare where good guys like Palla Pharma (ASX: PAL) have strengthened their balance sheet with the sale of their manufacturing facility

    Read More
    Public
  • Could this pharma company hold the answer to overuse of opioids?
    • News

    Could this pharma company hold the answer to overuse of opioids?

    Pain management is one of the most fascinating arms of medicine. Post-operative pain management, even more so. Practitioners must strike a balance to ensure that acute pain doesn’t turn into chronic pain, and that a patient’s dependence on analgesia is temporary. The many issues with opioid based pain medications are well documented and, with a

    Read More
    Public
  • Q&A: Paradigm to answer FDA questions to achieve Investigational New Drug status
    • News

    Q&A: Paradigm to answer FDA questions to achieve Investigational New Drug status

    The commercialisation of osteoarthritis treatment ZILOSUL® has hit a hiccup in the United States with the US Food and Drug Administration (FDA) raising fresh questions to late-stage drug development company, Paradigm Biopharmaceuticals (ASX: PAR). The FDA response related to Paradigm’s application for Investigational New Drug status to be granted for their focus compound, Pentosan Polysulfate

    Read More
    Public
  • Medical Developments gains approval to commence Penthrox trials in China
    • News

    Medical Developments gains approval to commence Penthrox trials in China

    Australian pharmaceuticals manufacturer Medical Developments International (ASX: MVP) has secured approval from the Chinese National Medical Product Administration (NMPA) to commence bridging trials for Penthrox IND, their green whistle pain reliever.  The approval is a major step towards commercialisation of the flagship non-opioid pain reliever in China.  “The approval of the Penthrox IND by the

    Read More
    Public
  • Australia’s green whistle pain relief winning over Europeans
    • News

    Australia’s green whistle pain relief winning over Europeans

    Carried and administered by Australian paramedics for decades, the green whistle pain reliever has been on the Australian market for years but clinical trials in Europe have now revealed Penthrox® to be a superior pain relief product than traditional treatments of morphine (IV), paracetamol, ketoprofen and NSAIDS.  Marketed as Penthrox® with the key ingredient of

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

Copyright © 2020 The Sentiment. All rights reserved.